“David J. Clark”

a.k.a.:  “David. J. Clark”

As a Name:  Registrant, Group Member and/or Signatory

        

Latest Filing:  2/28/24  as  ↓Signatory

As:  Registrant

        

As:  Signatory  (Director, Officer, Attorney, Accountant, Banker, Agent, etc.)

“David J. Clark” has been a Signatory for/with  37  Filers:

        

As Of	Filer			Filings       #        Latest		Issuer     (Primary)
2/28/24		NY	Schrodinger, Inc.	1	10-K	—
2/16/24		CA	Sientra, Inc.	7	8-K	—
2/14/24		MA	Cogent Biosciences, Inc.	1	8-K	—
1/25/24		PA	Windtree Therapeutics Inc./DE	1	8-K	—
11/9/23		CA	Acutus Medical, Inc.	4	8-K	—
8/24/23		CA	RayzeBio, Inc.	3	S-1	—
5/11/23		PA	Galera Therapeutics, Inc.	1	10-Q	—
3/8/23		CA	Invitae Corp.	1	8-K	—
11/14/22		MA	Clark David J	1	3	CT	Trevi Therapeutics, Inc.
8/15/22			ADC Therapeutics SA	5	6-K	—
6/1/22		FL	CareMax, Inc.	10	424B3	—
4/6/22		MA	HilleVax, Inc.	2	S-1	—
3/31/22		NY	DA32 Life Science Tech Acquisition Corp.	1	10-K	—
1/26/22		CA	Singular Genomics Systems, Inc.	3	8-K	—
12/8/21		MD	Elutia Inc.	2	8-K	—
11/19/21		NY	Flynn James E	1	SC 13D/A	CA	Oncology Institute, Inc.
10/1/21		MA	Xilio Therapeutics, Inc.	2	S-1	—
8/9/21		IL	ARCH Venture Fund XI, L.P.	1	SC 13D	NY	DA32 Life Science Tech Acquisition Corp.
8/9/21		NY	Deerfield Management Co., L.P. (Series C)	1	SC 13D	NY	DA32 Life Science Tech Acquisition Corp.
8/9/21		CA	Section 32 Fund 3, LP	1	SC 13D	NY	DA32 Life Science Tech Acquisition Corp.
			More...  Please Sign In to list all 37 of them.

“David J. Clark” has/had a Signatory interest in  6  Issuers:

As Of	Issuer			Filings       #        Latest		With Filer     (Primary)
11/14/22		CT	Trevi Therapeutics, Inc.	1	3	MA	Clark David J
11/19/21		CA	Oncology Institute, Inc.	1	SC 13D/A	NY	Flynn James E
8/9/21		NY	DA32 Life Science Tech Acquisition Corp.	3	SC 13D	IL	ARCH Venture Fund XI, L.P.
3/22/21		CO	Aytu Biopharma, Inc.	2	425	CO	Aytu Biopharma, Inc.
3/22/21		TX	Neos Therapeutics, Inc.	3	425	TX	Neos Therapeutics, Inc.
2/18/21		CT	Quantum-Si Inc.	1	425	CT	Quantum-Si Inc.